Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar

BackgroundSome studies have reported that influenza vaccination is associated with lower risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and/or coronavirus disease 2019 (COVID-19) morbidity and mortality. This study aims to estimate effectiveness of influenza vaccinati...

Full description

Saved in:

Bibliographic Details
Main Author:	Elias, Tayar (author)
Other Authors:	Abdeen, Sami (author), Abed Alah, Muna (author), Chemaitelly, Hiam (author), Bougmiza, Iheb (author), Ayoub, Houssein H. (author), Kaleeckal, Anvar Hassan (author), Latif, Ali Nizar (author), Shaik, Riyazuddin Mohammad (author), Al-Romaihi, Hamad Eid (author), Al-Thani, Mohamed H. (author), Bertollini, Roberto (author), Abu-Raddad, Laith J. (author), Al-Khal, Abdullatif (author)
Format:	article
Published:	2023
Subjects:	Influenza COVID-19 Vaccine Case-control Immunity Epidemiology
Online Access:	http://dx.doi.org/10.1016/j.jiph.2022.12.016 https://www.sciencedirect.com/science/article/pii/S1876034122003665 http://hdl.handle.net/10576/42680
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar
by: Elias Tayar (16488567)
Published: (2023)

Editorial of Harnessing the Power of T Cells: The Promising Hope for a Universal Influenza Vaccine
by: Salman M. Toor (8854751)
Published: (2020)

Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
by: Swapna, Thomas
Published: (2023)

Seasonal influenza disease and annual influenza vaccine coverage at Primary Health Care Corporation, Qatar, 2018–2019: a descriptive study
by: Seema Sylvia Dsouza (21347870)
Published: (2022)

Knowledge, attitudes, perceptions, and practice toward seasonal influenza and its vaccine: A cross-sectional study from a country of conflict
by: Wesam S. Ahmed (10170053)
Published: (2023)

Attitudes, motivators, and barriers toward influenza vaccination for children: a study from a conflict-ridden country
by: Wesam S. Ahmed (10170053)
Published: (2024)

Influenza prevalence and vaccine efficacy among diabetic patients in Qatar
by: Swapna Thomas (17337925)
Published: (2023)

Motivators and barriers of seasonal influenza vaccination among primary health care physicians in Qatar
by: Kamran Aziz (21633128)
Published: (2024)

BNT162b2 Versus mRNA‐1273 Vaccines: Comparative Analysis of Long‐Term Protection Against SARS‐CoV‐2 Infection and Severe COVID‐19 in Qatar
by: Hiam Chemaitelly (439114)
Published: (2024)

SARS‐CoV‐2 infection and effects of age, sex, comorbidity, and vaccination among older individuals: A national cohort study
by: Mai A. Mahmoud (9620657)
Published: (2023)

Seroprevalence and factors associated with SARS-CoV-2 infection among healthcare workers: cross-sectional study
by: Watheq Thabet Taher (17541210)
Published: (2023)

Antibody‐dependent enhancement (ADE) of SARS‐CoV‐2 in patients exposed to MERS‐CoV and SARS‐CoV‐2 antigens
by: Swapna Thomas (17337925)
Published: (2024)

T‐cell responses and therapies against SARS‐CoV‐2 infection
by: Salman M. Toor (8854751)
Published: (2023)

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
by: Heba N., Altarawneh
Published: (2023)

Comparative analysis of within-host diversity among vaccinated COVID-19 patients infected with different SARS-CoV-2 variants
by: Hebah A., Al-Khatib
Published: (2022)

Burden and disease pathogenesis of influenza and other respiratory viruses in diabetic patients
by: Swapna Thomas (17337925)
Published: (2022)

Computational and Transcriptome Analyses Revealed Preferential Induction of Chemotaxis and Lipid Synthesis by SARS-CoV-2
by: Hibah Shaath (5599658)
Published: (2020)

Molecular screening of phytocompounds targeting the interface between influenza A NS1 and TRIM25 to enhance host immune responses
by: Muhammad, Suleman
Published: (2024)

Effects of previous infection, vaccination, and hybrid immunity against symptomatic Alpha, Beta, and Delta SARS-CoV-2 infections: an observational study
by: Heba N. Altarawneh (19482436)
Published: (2023)

Severe Immune Thrombocytopenia Following MMR Vaccination with Rapid Recovery: A Case Report and Review of Literature
by: Majd Akbik (20382075)
Published: (2020)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
by: Suelen H., Qassim
Published: (2023)

Will Host Genetics Affect the Response to SARS-CoV-2 Vaccines? Historical Precedents
by: Maria K. Smatti (4675852)
Published: (2022)

Kikuchi-Fujimoto disease following SARS CoV2 vaccination: Case report
by: Hussam Al Soub (17269024)
Published: (2021)

SARS-CoV-2 and immune-microbiome interactions: Lessons from respiratory viral infections
by: Farhan, Cyprian
Published: (2021)

Neutralizing antibodies against SARS-CoV-2 are higher but decline faster in mRNA vaccinees compared to individuals with natural infection
by: Haissam Abou-Saleh (497840)
Published: (2022)

Evaluation of mortality attributable to SARS-CoV-2 vaccine administration using national level data from Qatar
by: Adeel A. Butt (3697705)
Published: (2023)

Report from the World Health Organization's immunization and vaccines-related implementation research advisory committee (IVIR-AC) meeting, virtual gathering, 10–13 September 2024
by: Lambach, Philipp
Published: (2025)

Will influenza A(H3N8) cause a major public health threat?
by: Hadi M., Yassine
Published: (2022)

Emerging COVID-19 variants and their impact on SARS-CoV-2 diagnosis, therapeutics and vaccines
by: Queenie Fernandes (14557388)
Published: (2022)

Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review
by: Maryam Arabi (3927509)
Published: (2023)

Qatar Healthcare Workers' COVID-19 Vaccine Hesitancy and Attitudes: A National Cross-Sectional Survey
by: Rajeev Kumar (195329)
Published: (2021)

Addressing bias in the definition of SARS-CoV-2 reinfection: implications for underestimation
by: Hiam Chemaitelly (439114)
Published: (2024)

Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
by: Hiam, Chemaitelly
Published: (2023)

Population immunity of natural infection, primary-series vaccination, and booster vaccination in Qatar during the COVID-19 pandemic: an observational study
by: Suelen H. Qassim (13777594)
Published: (2023)

Follow‐Up and Comparative Assessment of SARS‐CoV‐2 IgA, IgG, Neutralizing, and Total Antibody Responses After BNT162b2 or mRNA‐1273 Heterologous Booster Vaccination
by: Salma Younes (6424865)
Published: (2024)

Assessment of the Neutralizing Antibody Response of BNT162b2 and mRNA-1273 SARS-CoV-2 Vaccines in Naïve and Previously Infected Individuals: A Comparative Study
by: Farah M. Shurrab (16324961)
Published: (2022)

Follow up and comparative assessment of IgG, IgA, and neutralizing antibody responses to SARS-CoV-2 between mRNA-vaccinated naïve and unvaccinated naturally infected individuals over 10 months
by: Salma, Younes
Published: (2023)

Mapping routine measles vaccination in low- and middle-income countries
by: Local Burden of Disease Vaccine Coverage Collaborators (11548903)
Published: (2020)

<i>In silico </i>formulation of a next-generation multiepitope vaccine for use as a prophylactic candidate against Crimean-Congo hemorrhagic fever
by: Rahat Alam (9286527)
Published: (2023)

Short- and longer-term all-cause mortality among SARS-CoV-2- infected individuals and the pull-forward phenomenon in Qatar: a national cohort study
by: Hiam Chemaitelly (439114)
Published: (2023)